Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remis... (original) (raw)

Low-Dose Total-Body Irradiation and Fludarabine Followed by Hematopoietic Cell Transplantation From HLA-Identical Sibling Donors Do Not Induce Complete T-Cell Donor …

Carmen martínez

Experimental …, 2003

View PDFchevron_right

Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donor

M Kami

2004

View PDFchevron_right

Low-Dose Total Body Irradiation and Fludarabine Conditioning for HLA Class I-Mismatched Donor Stem Cell Transplantation and Immunologic Recovery in Patients with Hematologic Malignancies: A Multicenter Trial

James Wade

Biology of Blood and Marrow Transplantation, 2010

View PDFchevron_right

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

john slattery

View PDFchevron_right

LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A-, HLA-B-, AND HLA-DR-COMPATIBLE DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES1

Tina Dalianis

Transplantation, 1998

View PDFchevron_right

Transplantation of HLA-mismatched CD34+ selected cells in patients with advanced malignancies: severe immunodeficiency and related complications

N. Mordini

British Journal of Haematology, 1997

View PDFchevron_right

Marrow transplantation from HLA non-identical family donors for the treatment of leukaemia: a pilot study of 15 patients using additional immunosuppression and T-cell depletion

Philippe Montcuquet

British Journal of Haematology, 2008

View PDFchevron_right

Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation

Marianne Hokland

Bone Marrow Transplantation

View PDFchevron_right

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

Michael Maris

Blood, 2004

View PDFchevron_right

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia

Michael Maris

Biology of Blood and Marrow Transplantation, 2005

View PDFchevron_right

Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning …

Richard Maziarz

Biology of Blood and …, 2008

View PDFchevron_right

Unrelated Donor Hematopoietic Cell Transplantation: Factors Associated with a Better HLA Match

Arturo Molina, Koen van Besien

Biology of Blood and Marrow Transplantation, 2008

View PDFchevron_right

Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the acute leukemia working party of the EBMT

Denis-claude Roy

Haematologica

View PDFchevron_right

Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors

Boris Fehse

Experimental Hematology, 2008

View PDFchevron_right

Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders

Michael Loken

Bone Marrow Transplantation, 2007

View PDFchevron_right

Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide

Mary Leffell

Biology of Blood and Marrow Transplantation, 2002

View PDFchevron_right

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts

John Wingard

Blood, 2011

View PDFchevron_right

Donor Age and Degree of Hla Matching Have a Major Impact on the Outcome of Unrelated Haematopoietic Cell …

C. Canizo

View PDFchevron_right

Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab from HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients with Hematologic Malignancies

Stephen Schey

Biology of Blood and Marrow Transplantation, 2014

View PDFchevron_right

HLA-Matched Related Donor Hematopoietic Cell Transplantation in 43 Patients with Fanconi Anemia Conditioned with 60 mg/kg of Cyclophosphamide

Marco Bitencourt, Vaneuza Funke

Biology of Blood and Marrow Transplantation, 2007

View PDFchevron_right

Novel strategies for adoptive therapy following HLA disparate transplants

Aisha Hasan

Best Practice & Research Clinical Haematology, 2011

View PDFchevron_right

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

Brenda Sandmaier

Blood, 2004

View PDFchevron_right

16th IHIW: International Histocompatibility Working Group in Hematopoietic Cell Transplantation

Eric Spierings, Anne Cesbron

International Journal of Immunogenetics, 2012

View PDFchevron_right

Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants

ISABEL Cunningham

Blood, 1989

View PDFchevron_right

6th IHIW: International Histocompatibility Working Group in Hematopoietic Cell Transplantation

Eric Spierings

View PDFchevron_right

Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen

Daniel Olive

Experimental Hematology, 2003

View PDFchevron_right

Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus

Jack Singer

Blood, 1993

View PDFchevron_right

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning

R. Hough

Blood, 2010

View PDFchevron_right

Using Related Donors other Than Genotypically HLA-Matched Siblings in Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Disease: A Single Institution Experience in Japan

Shigetaka Asano, Satoshi Takahashi

International Journal of Hematology, 2002

View PDFchevron_right

Marrow transplants from unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiation

Michael Amylon

Biology of Blood and Marrow Transplantation, 2001

View PDFchevron_right